Results 221 to 230 of about 78,778 (305)

ADGRE2: A Promising Immunotherapeutic Target in Acute Myeloid Leukemia and Chronic Myelomonocytic Leukemia

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Acute myeloid leukemia (AML) and chronic myelomonocytic leukemia (CMML) are heterogeneous myeloid malignancies with limited therapeutic options and often poor long‐term prognosis due to persistence of therapy‐resistant leukemic stem cells (LSC).
Jennifer Neiss   +9 more
wiley   +1 more source

Therapeutic biologics interference in serological and pre-transfusion testing. [PDF]

open access: yesFront Immunol
Trummer P   +3 more
europepmc   +1 more source

Posttranslational Modification Cross‐Talk in Vascular Cells: Molecular Mechanisms and Therapeutic Implications for Atherosclerosis

open access: yesCell Biochemistry and Function, Volume 44, Issue 11, November 2026.
ABSTRACT Atherosclerosis is driven by coordinated changes in endothelial cells (ECs), macrophages, and vascular smooth muscle cells (VSMCs). Post‐translational modifications (PTMs), phosphorylation, acetylation, ubiquitination, SUMOylation, O‐GlcNAcylation, palmitoylation, ISGylation, and ADP‐ribosylation, integrate metabolic, inflammatory, and ...
Weiwei Jiang, Haiping Du
wiley   +1 more source

Aggressive Hepatic AL Amyloidosis Encountering Therapeutic Frailty: Rapid Organ Reversal With Tailored Daratumumab‐Based Therapy and Low‐Dose Corticosteroids in a Patient With Steroid‐Induced Psychosis

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT Hepatic AL amyloidosis can cause severe cholestasis independent of marrow tumor burden. In patients with absolute contraindications to high‐dose steroids—such as steroid‐induced psychosis—tailored daratumumab regimens with low‐dose corticosteroids can drive rapid, life‐saving organ reversal.
R. Ceccarelli   +8 more
wiley   +1 more source

Distinct monocyte phenotypes are associated with peri-coronary inflammation in persons with and without HIV and without cardiovascular disease. [PDF]

open access: yesFront Immunol
Stephens VR   +12 more
europepmc   +1 more source

A Case of Mistaken Identity: Managing Sweet Syndrome Following Recurrent Debridement

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT Acute febrile neutrophilic dermatosis (Sweet Syndrome) is often misdiagnosed as a severe skin and soft tissue infection, which delays management of the underlying condition and can cause severe morbidity from incorrect management. To prevent this, one should be open to utilizing a multi‐disciplinary approach and be mindful of anchoring.
Dean E. Watkins   +4 more
wiley   +1 more source

Integrated Genomic Characterization of Aggressive Multiple Myeloma With 1q21 Gain Reveals IL6R‐Associated Chromatin Remodeling: A Case Report

open access: yesCancer Reports, Volume 9, Issue 11, November 2026.
ABSTRACT Background Chromosome 1q21 gain is a frequent secondary abnormality in multiple myeloma, yet its clinical impact depends heavily on coexisting genomic lesions. The regulatory consequences of this abnormality at the three‐dimensional chromatin level remain poorly understood.
Haibo Liu   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy